Trademark Details For LEOVYLAS (Serial Number 79300608)

  •  Home
  •  Print
LEOVYLAS
1
6
3
0
Serial Number  United States - USPTO 79300608
Registration Number 6436582
Mark
LEOVYLAS
Filing Date Oct-28-2020
Status
Registered  
REGISTERED (700)
REGISTERED
Attorney Name
TTAB
0
Action Tags
  




005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameLegal Brand Protection, GlaxoSmithKline
AddressGSK House, 980 Great West Road BRENTFORD, Middlesex TW8 9GS UNITED KINGDOM

Prosecution History

  
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Dec-24-2020SN ASSIGNED FOR SECT 66A APPL FROM IB   REPRM
Jan-07-2021LIMITATION FROM ORIGINAL APPLICATION ENTERED   LIMII
Jan-11-2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Jan-15-2021APPLICATION FILING RECEIPT MAILED   MAFRO
Mar-13-2021LIMITATION OF GOODS RECEIVED FROM IB   LIMGM
Mar-20-2021LIMITATION OF GOODS RECEIVED FROM IB   LIMGM
Mar-26-2021LIMITATION FROM THE IB EXAMINED AND ENTERED   LIMEI
Mar-30-2021ASSIGNED TO EXAMINER   DOCKD
Apr-12-2021APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Apr-14-2021LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED   LIMNI
Apr-28-2021NOTICE OF PUBLICATION   NPUBO
Apr-28-2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB   OP2RP
Apr-28-2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB   OPNSP
May-17-2021NOTIFICATION PROCESSED BY IB   GPNXP
May-18-2021PUBLISHED FOR OPPOSITION   PUBOA
Jul-10-2021LIMITATION OF GOODS RECEIVED FROM IB   LIMGM
Jul-20-2021LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED   LIMNI
Aug-03-2021REGISTERED-PRINCIPAL REGISTER   R.PRA
Sep-02-2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB   GPARP
Sep-15-2021FINAL DISPOSITION PROCESSED   FIMPP
Sep-15-2021FINAL DISPOSITION NOTICE SENT TO IB   FICSP
Oct-03-2021NOTIFICATION PROCESSED BY IB   GPNXP
Jul-28-2023CHANGE OF NAME/ADDRESS REC'D FROM IB   ADCHM